JP2016501857A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016501857A5 JP2016501857A5 JP2015543431A JP2015543431A JP2016501857A5 JP 2016501857 A5 JP2016501857 A5 JP 2016501857A5 JP 2015543431 A JP2015543431 A JP 2015543431A JP 2015543431 A JP2015543431 A JP 2015543431A JP 2016501857 A5 JP2016501857 A5 JP 2016501857A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- amino acids
- side chains
- amino acid
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1220901.1A GB201220901D0 (en) | 2012-11-21 | 2012-11-21 | CD44v6-derived peptides for treating pancreatic cancer |
| GB1220901.1 | 2012-11-21 | ||
| PCT/EP2013/074401 WO2014079940A1 (en) | 2012-11-21 | 2013-11-21 | Cd44v6-derived peptides for treating pancreatic cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016501857A JP2016501857A (ja) | 2016-01-21 |
| JP2016501857A5 true JP2016501857A5 (https=) | 2016-12-22 |
Family
ID=47521471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015543431A Pending JP2016501857A (ja) | 2012-11-21 | 2013-11-21 | 膵癌を処置するためのｃｄ４４ｖ６由来ペプチド |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9586993B2 (https=) |
| EP (1) | EP2922561A1 (https=) |
| JP (1) | JP2016501857A (https=) |
| GB (1) | GB201220901D0 (https=) |
| WO (1) | WO2014079940A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201421647D0 (en) * | 2014-12-05 | 2015-01-21 | Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie | CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases |
| EP4464714A1 (en) | 2023-05-19 | 2024-11-20 | Karlsruher Institut für Technologie | Screening method for cell-repelling peptides |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19540515C1 (de) * | 1995-10-31 | 1997-02-06 | Boehringer Ingelheim Int | Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten |
| GB9901710D0 (en) | 1999-01-26 | 1999-03-17 | Prolifix Ltd | Peptide inhibitors |
| EP1258255A1 (en) | 2001-05-18 | 2002-11-20 | Boehringer Ingelheim International GmbH | Conjugates of an antibody to CD44 and a maytansinoid |
| EP1391213A1 (en) | 2002-08-21 | 2004-02-25 | Boehringer Ingelheim International GmbH | Compositions and methods for treating cancer using maytansinoid CD44 antibody immunoconjugates and chemotherapeutic agents |
| EP1417974A1 (en) * | 2002-11-08 | 2004-05-12 | Boehringer Ingelheim International GmbH | Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy |
| AR046774A1 (es) * | 2003-12-24 | 2005-12-21 | Boehringer Ingelheim Pharma | Formulacion liofilizada de conjugados de anticuerpos |
| EP1647556B1 (en) * | 2004-10-14 | 2010-05-19 | Karlsruher Institut für Technologie | Peptidic compounds and derivatives thereof for the treatment of human diseases through inhibition of signaling via growth factors |
| EP2002259B1 (en) | 2006-04-10 | 2012-05-16 | Genentech, Inc. | Disheveled PDZ modulators |
| DK2193142T3 (da) | 2007-08-30 | 2015-04-20 | Curedm Group Holdings Llc | Præparater og fremgangsmåder til anvendelse af pro-øcellepeptider og analoger dertil |
| EP2218457B1 (en) * | 2009-02-16 | 2011-09-07 | Karlsruher Institut für Technologie | CD44v6 peptides as inhibitors of bacterial infections |
| EP2266593A1 (en) * | 2009-06-24 | 2010-12-29 | Karlsruher Institut für Technologie | Use of CD44v6 in the treatment of ophthalmic diseases |
| WO2011022335A1 (en) * | 2009-08-21 | 2011-02-24 | Mount Sinai School Of Medicine Of New York University | Methods of using cd44 fusion proteins to treat cancer |
| US20120258998A1 (en) * | 2011-04-05 | 2012-10-11 | Patrick Tan | Fusion genes in gastrointestinal cancer |
-
2012
- 2012-11-21 GB GBGB1220901.1A patent/GB201220901D0/en not_active Ceased
-
2013
- 2013-11-21 JP JP2015543431A patent/JP2016501857A/ja active Pending
- 2013-11-21 WO PCT/EP2013/074401 patent/WO2014079940A1/en not_active Ceased
- 2013-11-21 EP EP13794910.3A patent/EP2922561A1/en not_active Withdrawn
- 2013-11-21 US US14/407,244 patent/US9586993B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20140185T1 (hr) | Peptidi i njihova primjena | |
| BR112018076437A2 (pt) | interferon porcino peguilado e seus métodos de utilização | |
| PH12014501642B1 (en) | Peptide vaccines for cancers expressing tumor-associated antigens | |
| UA100127C2 (ru) | Пептид cdh3 и лекарственное средство, содержащее его | |
| JP2016222689A5 (ja) | 合成ペプチド及び乾燥粉末薬剤輸送システム | |
| AU2017248121A1 (en) | T cell receptors | |
| AU2017248120A1 (en) | T cell receptors | |
| EA201500802A1 (ru) | Способы профилактики и/или лечения кардиомиопатии и устранения симптомов кардиомиопатии, фармацевтическая композиция, векторы | |
| AR103891A1 (es) | Proteínas de unión a tslp, ácido nucleico aislado que la codifica, vector y célula hospedadora que lo comprenden, método para producir dicha proteína, su uso para fabricar un medicamento, composición farmacéutica y kit que la comprenden | |
| MX366906B (es) | Purificacion de iduronato-2-sulfatasa. | |
| JPWO2019156137A5 (https=) | ||
| HRP20201081T1 (hr) | Inhibitorni peptidi porijeklom od trem-sličnog transkripta 1 (tlt-1) i njihove uporabe | |
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| JP2016501858A5 (https=) | ||
| MY205028A (en) | Protein for treatment of inflammatory diseases | |
| TN2017000520A1 (en) | Compositions and methods for treating celiac sprue disease | |
| BR112018073669A2 (pt) | proteína de fusão, composição de uma primeira proteína e uma segunda proteína, complexo de uma primeira proteína e uma segunda proteína, polinucleotídeos que codificam uma proteína de fusão, vetor contendo o polinucleotídeo, célula hospedeira contendo o polinucleotídeo, uso de uma proteína de fusão, composição farmacêutica, e composição farmacêutica para uso | |
| WO2008093058A3 (en) | Peptides and their use | |
| MX2009013682A (es) | Enlazador de fmoc polimerico hidrolizable. | |
| IN2014DN09963A (https=) | ||
| BR112015000183A2 (pt) | proteínas de superfície específicas de variante (vsp) de protozoário como carreadores para entrega de fármaco oral | |
| JP2016501857A5 (https=) | ||
| JP2016516054A5 (https=) | ||
| WO2010103515A3 (en) | Compositions and methods for prevention and treatment of neurodegenerative diseases | |
| MX2010005816A (es) | Epítopos de péptido de stat3. |